Sobi to streamline nirsevimab contractual arrangements : vim

Nirsevimab economics simplified through a new royalty agreement with Sanofi and the termination of the participation agreement with AstraZeneca

 

Alignment will provide Sobi benefit through... | April 9, 2023

Related Keywords

Stockholm , Sweden , United States , Australia , America , Thomas Kudsk Larsen , Sobi Investor Relations Team , Astrazeneca , For Sobi Media , Swedish Orphan Biovitrum Ab Publ Stock Exchange , News , Information , Press Release , Nirsevimab , Conomics , Simplified , Through , Few , Royalty , Agreement , Ith , Sanofi , End , The , Termination , F , Participation , Hill , Rovide , Gobi , Enefit Sobi Se0000872095 ,